Cargando…
Transmission of Exosomal TPX2 Promotes Metastasis and Resistance of NSCLC Cells to Docetaxel
BACKGROUND: Lung cancer, most of which is non-small cell lung cancer (NSCLC), is the most common tumor in the world, and drug resistance, as a major problem in clinical treatment, has attracted extensive attention. However, the role and mechanism of Targeting protein for Xenopus kinesin-like protein...
Autores principales: | Hu, Jiaru, He, Qing, Tian, Tian, Chang, Na, Qian, Liting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10065223/ https://www.ncbi.nlm.nih.gov/pubmed/37009264 http://dx.doi.org/10.2147/OTT.S401454 |
Ejemplares similares
-
Systematic comparison of TPX and TPX3 devices regarding luminosity measurements in the ATLAS cavern
por: Fiedler, Petr
Publicado: (2021) -
Evaluation of efficacy and toxicity of nivolumab combined with or without docetaxel in patients with advanced NSCLC
por: Wang, Yang, et al.
Publicado: (2021) -
TPX2 is a novel prognostic marker for the growth and metastasis of colon cancer
por: Wei, Ping, et al.
Publicado: (2013) -
TPX2 Promotes Metastasis and Serves as a Marker of Poor Prognosis in Non-Small Cell Lung Cancer
por: Zhou, Fang, et al.
Publicado: (2020) -
Ratiometric electrochemical OR gate assay for NSCLC-derived exosomes
por: Meng, Fanyu, et al.
Publicado: (2023)